This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
05/06/15 - 10:00:53 AM ET (BATS BZX Real-time Price)
Div Yield: --
AMAG Day's Range
AMAG 52 Week Range
AMAG Business Summary
AMAG Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that focuses on maternal health, anemia, and cancer supportive care.View AMAG key stats
AMAG Pharmaceuticals Inc - AMAG - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates AMAG Pharmaceuticals Inc as a
Buy with a ratings score of B.
Report Snippet: We rate AMAG PHARMACEUTICALS INC (AMAG) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, attractive valuation levels, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.